Clinical Trial Update: Study of Gamma PN3 in the Elderly [Phase 1]

View source ↗

Summary

Phase 1 study of Gamma PN3 in elderly participants has completed, evaluating its use in pneumococcal pneumonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Pneumonia
• Pneumonia

Drugs mentioned

• Gamma-PN3

Snippet

Sponsor: GPN Vaccines | Conditions: Pneumonia, Pneumococcal | Phase 1 | Status: COMPLETED